Diabetes in Nigeria: Why Millions Struggle

✓ Medically reviewed | Published: | Evidence level: 1A
A Nigerian diabetes association has estimated that about 11.4 million people in the country live with diabetes, and that most cannot afford treatment. The situation illustrates a wider pattern in lower-resource settings, where out-of-pocket costs for insulin, testing supplies and complication care drive poor outcomes.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Public Health

Quick Facts

Reported Cases
About 11.4 million
Key Barrier
Treatment cost
Source
Nigerian diabetes association

How common is diabetes in Nigeria and why does cost matter?

Quick answer: An association estimates 11.4 million Nigerians have diabetes, and because many pay out of pocket, cost often determines whether people get consistent care.

According to figures cited by a Nigerian diabetes association and reported by LEADERSHIP Newspapers, roughly 11.4 million Nigerians are living with diabetes, and most are unable to afford treatment. Such estimates differ by source and methodology, and a large share of cases in many countries remain undiagnosed, so the true burden may be higher or lower than any single figure suggests.

Diabetes management is a lifelong expense. Medicines, glucose test strips, laboratory monitoring, eye and foot checks, and treatment of complications all add up. Where health insurance coverage is limited and households pay directly, people may ration medication, skip monitoring or seek care only when complications develop. This raises the risk of kidney disease, vision loss, amputation and cardiovascular events.

What can improve diabetes care in low-resource settings?

Quick answer: Measures such as earlier detection, affordable essential medicines, primary-care-based management and broader insurance coverage can reduce complications.

The World Health Organization has emphasized that access to affordable essential diabetes medicines, including insulin, and to basic monitoring remains uneven worldwide, particularly in low- and middle-income countries. Its guidance favors strengthening primary care so that blood sugar, blood pressure and cholesterol can be managed together at lower cost.

Practical steps include community screening to find undiagnosed cases, generic and biosimilar options to lower prices, patient education on diet and activity, and insurance schemes that cover chronic-disease care. Prevention also matters: for type 2 diabetes, weight management, physical activity and healthy diets reduce risk. These measures are most effective when combined with reliable supply chains so that medicines are available when patients need them.

Frequently Asked Questions

Early type 2 diabetes may cause few or no symptoms, and where routine screening is limited, it can go undetected until complications such as vision problems or kidney damage appear.

Poorly controlled blood sugar raises the risk of acute problems and long-term complications involving the eyes, kidneys, nerves and heart. People who cannot afford their medication should ask a clinician or local health program about lower-cost options.

Yes. Evidence indicates that maintaining a healthy weight, being physically active and eating a balanced diet can lower the risk of developing type 2 diabetes, or delay it in people at high risk.

References

  1. World Health Organization. Diabetes fact sheet. Updated 2024.
  2. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. 2021.
  3. LEADERSHIP Newspapers. 11.4m Nigerians Living With Diabetes, Most Unable To Afford Treatment – Association. November 2026.